Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer
NCT00139711
ABOUT THIS STUDY
FOR MORE INFORMATION
Contact a representative by phone, email, or visiting the study website. Please see the references below:
Pfizer Clinical Trials Contact Center
1-800-718-1021
- Histologically or cytologically proven NSCLC
- Recurrent or metastatic NCSLC
- Prior malignancies; except for cured non melanoma skin cancer, curatively treated in
situ carcinoma of the cervix or other cancer adequately treated an with non evidence
of disease for at least 5 years
- History or presence of brain or meningeal metastases
NEED INFO?
Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center Representative
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- Las Vegas, Nevada
- Camperdown, New South Wales
- Fresno, California
- Glendale, California
- Long Beach, California
- Los Angeles, California
- Santa Ana, California
- Whittier, California
- Whittier, California
- Greenbrae, California
- La Jolla, California
- LaJolla, California
- San Diego, California
- San Mateo, California
- Tampa, Florida
- Ann Arbor, Michigan
- Detroit, Michigan
- Farmington Hills, Michigan
- Coon Rapids, Minnesota
- Fridley, Minnesota
- Robbinsdale, Minnesota
- New York, New York
- Philadelphia, Pennsylvania
- Baltimore, Maryland
- St. Louis, Missouri
- St. Louis, Missouri
- St. Peters, Missouri
- Chapel Hill, North Carolina
- Clinton, North Carolina
- Goldsboro, North Carolina
- Pollocksville, North Carolina
- Wilson, North Carolina
- Pittsburgh, Pennsylvania
- Charlottesville, Virginia
- Orbassano (Torino),
- Badalona, Barcelona
- Barcelona,
- Birmingham, Alabama
- Birmingham, Alabama
- Little Rock, Arkansas
- Bakersfield, California
- Beverly Hills, California
- Beverly Hills, California
- La Jolla, California
- La Jolla, California
- Los Angeles, California
- Los Angeles, California
- Los Angeles, California
- Los Angeles, California
- Orange, California
- Orange, California
- Palo Alto, California
- Sacramento, California
- Sacramento, California
- San Diego, California
- Santa Monica, California
- Santa Monica, California
- Santa Monica, California
- Santa Rosa, California
- Aurora, Colorado
- Aurora, Colorado
- Aurora, Colorado
- Denver, Colorado
- Lafayette, Colorado
- New Haven, Connecticut
- New Haven, Connecticut
- New Haven, Connecticut
- Fort Lauderdale, Florida
- Hollywood, Florida
- Lake Worth, Florida
- Pembroke Pines, Florida
- Tampa, Florida
- Atlanta, Georgia
- Atlanta, Georgia
- Atlanta, Georgia
- Atlanta, Georgia
- Atlanta, Georgia
- Atlanta, Georgia
- Augusta, Georgia
- Augusta, Georgia
- Augusta, Georgia
- Decatur, Georgia
- Macon, Georgia
- Marietta, Georgia
- Sandy Springs, Georgia
- Honolulu, Hawaii
- Honolulu, Hawaii
- Honolulu, Hawaii
- Chicago, Illinois
- Chicago, Illinois
- Chicago, Illinois
- Harvey, Illinois
- Harvey, Illinois
- Harvey, Illinois
- Tinley Park, Illinois
- Indianapolis, Indiana
- Indianapolis, Indiana
- Indianapolis, Indiana
- Indianapolis, Indiana
- Indianopolis, Indiana
- Munster, Indiana
- Munster, Indiana
- Baltimore, Maryland
- Baltimore, Maryland
- Bethesda, Maryland
- Boston, Massachusetts
- Boston, Massachusetts
- Boston, Massachusetts
- Boston, Massachusetts
- Boston, Massachusetts
- Boston, Massachusetts
- Boston, Massachusetts
- Detroit, Michigan
- Farmington Hills, Michigan
- St. Louis, Missouri
- St. Louis, Missouri
- St. Peters, Missouri
- Omaha, Nebraska
- Lebanon, New Hampshire
- Albuquerque, New Mexico
- Albuquerque, New Mexico
- Lake Success, New York
- Manhasset, New York
- New Hyde Park, New York
- New York, New York
- New York, New York
- New York, New York
- New York, New York
- Oneida, New York
- Oswego, New York
- Syracuse, New York
- Syracuse, New York
- Chapel Hill, North Carolina
- Chapel Hill, North Carolina
- Charlotte, North Carolina
- Huntersville, North Carolina
- Huntersville, North Carolina
- Matthews, North Carolina
- Cleveland, Ohio
- Columbus, Ohio
- Columbus, Ohio
- Columbus, Ohio
- Columbus, Ohio
- Portland, Oregon
- Hershey, Pennsylvania
- Philadelphia, Pennsylvania
- Philadelphia, Pennsylvania
- Philadelphia, Pennsylvania
- Pittsburgh, Pennsylvania
- East Providence, Rhode Island
- East Providence, Rhode Island
- Charleston, South Carolina
- Dickson, Tennessee
- Franklin, Tennessee
- Gallatin, Tennessee
- Hermitage, Tennessee
- Lebanon, Tennessee
- Murfreesboro, Tennessee
- Nashville, Tennessee
- Nashville, Tennessee
- Nashville, Tennessee
- Nashville, Tennessee
- Nashville, Tennessee
- Nashville, Tennessee
- Nashville, Tennessee
- Nashville, Tennessee
- Smyrna, Tennessee
- Dallas, Texas
- Dallas, Texas
- Dallas, Texas
- Dallas, Texas
- Houston, Texas
- Seattle, Washington
- Seattle, Washington
- Seattle, Washington
- Seattle, Washington
- Seattle, Washington
- Camperdown, New South Wales
- Adelaide, South Australia
- East Melbourne, Victoria
- Nedlands, Western Australia
- Salvador, Bahia
- Rio de Janeiro, RJ
- Ijui, RS
- Porto Alegre, RS
- Porto Alegre, RS
- Jau, Sao Paulo
- Barretos, SP
- Sao Paulo, SP
- Sao Paulo, SP
- Sofia,
- Sofia,
- Sofia,
- Varna,
- Calgary, Alberta
- Calgary, Alberta
- Calgary, Alberta
- Edmonton, Alberta
- Moncton, New Brunswick
- Moncton, New Brunswick
- Oshawa, Ontario
- Oshawa, Ontario
- Ottawa, Ontario
- Montreal, Quebec
- Montreal, Quebec
- Montreal, Quebec
- Montreal, Quebec
- Montreal, Quebec
- Guangzhou, Guangdong
- Nanjing, Jiangsu
- Beijing,
- Beijing,
- Guangzhou,
- Shanghai,
- Shanghai,
- Shanghai,
- Shanghai,
- Caen Cedex 05,
- Dijon,
- Grenoble Cedex 09,
- Marseille Cedex 20,
- NICE Cedex 2,
- Paris cedex 20,
- Paris,
- St Herblain Cedex,
- Villejuif,
- Dresden,
- Essen,
- Grosshansdorf,
- Hamburg,
- Heidelberg,
- Koeln,
- Muenchen,
- Oldenburg,
- Wiesbaden,
- Heraklion, Crete
- Exohi, Thessaloniki
- Athens,
- Pokfulam,
- Shatin, New Territories,
- Tuen Mun, New Territories,
- Budapest,
- Budapest,
- Debrecen,
- Farkasgyepu,
- Szekesfehervar,
- Torokbalint,
- Dublin,
- Dublin,
- Galway,
- Galway,
- Galway,
- Avellino,
- Firenze,
- Genova,
- Lido di Camaiore (LU),
- Lucca,
- Milano,
- Milano,
- Milano,
- Milano,
- Monza,
- Orbassano (TO),
- Perugia,
- Roma,
- Torino,
- Nagoya, Aichi
- Sapporo, Hokkaido
- Akashi, Hyogo
- Osakasayama-shi, Osaka
- Sunto-gun, Shizuoka
- Chuo-ku, Tokyo
- Fukuoka,
- Kashiwa,
- Okayama,
- Tokyo,
- Gyeonggi-do,
- Seoul,
- Seoul,
- Groningen,
- Gdansk,
- Olsztyn,
- Olsztyn,
- Olsztyn,
- Olsztyn,
- Poznan,
- Poznan,
- Kazan,
- Moscow,
- Saint-Petersburg,
- Saint-Petersburg,
- Saint-Petersburg,
- St. Petersburg,
- Oviedo, Asturias
- Badalona, Barcelona
- L'hospitalet de Llobregat, Barcelona
- Sabadell, Barcelona
- A Coruña, Galicia
- Barcelona,
- Barcelona,
- Madrid,
- Pamplona,
- Santander,
- Sevilla,
- Stockholm,
- Tainan,
- Taipei,
- Taipei,
- Headington, Oxford
- Sutton, Surrey
- Eastleigh,
- London,
- London,
- London,
- Manchester,
- Southampton,
Descriptive Information | ||||
---|---|---|---|---|
Brief Title ICMJE | Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer | |||
Official Title ICMJE | A Multicenter Randomized Phase II Study Evaluating The Activity And Tolerability Of Three Different Combinations Of Docetaxel (Taxotere) And Irinotecan (Campto) As Second Line Therapy For Recurrent Or Metastatic Non Small Cell Lung Cancer (NSCLS) | |||
Brief Summary | A multicenter randomized phase II study evaluating the activity and tolerability of three different combinations of docetaxel (taxotere) and irinotecan (campto) as second line therapy for recurrent or metastatic non small cell lung cancer (NSCLC) | |||
Detailed Description | Not Provided | |||
Study Type ICMJE | Interventional | |||
Study Phase ICMJE | Phase 2 | |||
Study Design ICMJE | Allocation: Randomized Intervention Model: Parallel Assignment Masking: None (Open Label) Primary Purpose: Treatment | |||
Condition ICMJE | Carcinoma, Non-Small-Cell Lung | |||
Intervention ICMJE |
| |||
Study Arms ICMJE | Not Provided | |||
Publications * | Not Provided | |||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. | ||||
Recruitment Information | ||||
Recruitment Status ICMJE | Completed | |||
Enrollment ICMJE | 138 | |||
Original Enrollment ICMJE | Same as current | |||
Study Completion Date ICMJE | June 2006 | |||
Primary Completion Date | Not Provided | |||
Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
| |||
Sex/Gender ICMJE |
| |||
Ages ICMJE | 18 Years to 70 Years (Adult, Older Adult) | |||
Accepts Healthy Volunteers ICMJE | No | |||
Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | |||
Listed Location Countries ICMJE | Italy | |||
Removed Location Countries | ||||
Administrative Information | ||||
NCT Number ICMJE | NCT00139711 | |||
Other Study ID Numbers ICMJE | XRP6976C/2501 A5961088 | |||
Has Data Monitoring Committee | Not Provided | |||
U.S. FDA-regulated Product | Not Provided | |||
IPD Sharing Statement ICMJE | Not Provided | |||
Responsible Party | Not Provided | |||
Study Sponsor ICMJE | Pfizer | |||
Collaborators ICMJE | Not Provided | |||
Investigators ICMJE |
| |||
PRS Account | Pfizer | |||
Verification Date | October 2006 | |||
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |